# International PMS Study - KOGENATE Bayer

> **NCT00864552** · — · COMPLETED · sponsor: **Bayer** · enrollment: 200 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **DRUG:** Kogenate (BAY14-2222)

## Key facts

- **NCT ID:** NCT00864552
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2009-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00864552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00864552, "International PMS Study - KOGENATE Bayer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00864552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*